Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy

Immune-related adverse events (irAEs) can impair the effectiveness and safety of immune checkpoint inhibitors (ICIs) and restrict the clinical applications of ICIs in oncology. The predictive biomarkers of irAE are urgently required for early diagnosis and subsequent management. The exact mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiujing, Yu, Jing, Shi, Hubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652050/
https://www.ncbi.nlm.nih.gov/pubmed/34899357
http://dx.doi.org/10.3389/fphar.2021.797852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652050/
https://www.ncbi.nlm.nih.gov/pubmed/34899357
http://dx.doi.org/10.3389/fphar.2021.797852

Ejemplares similares